Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06414356 · ClinicalTrials.gov registry record · Phase 4

The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD

A Phase 4 study of PTSD and Neuropathic Pain, sponsored by Margaux M. Salas, PhD.

Recruiting
Registry status
Phase 4
Development phase
30
Enrollment target
1
Study location

NCT06414356 is a Phase 4 study of PTSD and Neuropathic Pain that is actively recruiting participants, run by Margaux M. Salas, PhD. The registered enrollment target is 30 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06414356, a Phase 4 study of PTSD and Neuropathic Pain, is actively recruiting participants, sponsored by Margaux M. Salas, PhD.

RECRUITING
Registry status
Phase 4
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study is aimed to evaluate outpatient ketamine infusion within a military chronic neuropathic pain population and its effect on PTSD. Currently, this is a pilot study with 30 participants. Participants will be randomized to (1) a moderate dose ketamine, (2) moderate dose ketamine +Mg, or (3) a magnesium control group. Participants will complete self-reported pain and PTSD questionnaires throughout the \~24-week study period. The outlined strategy will provide evidence for the utility of ketamine in neuropathic pain management and pain associated comorbidities within a military population.

Conditions Studied

PTSD Neuropathic Pain

Interventions

  • DRUG Ketamine
  • DRUG Magnesium sulfate
  • DRUG Ketamine + Magnesium sulfate

Study Locations (1)

Texas

  • Brooke Army Medical Center - San Antonio

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-10-02
Est. Completion 2027-05
Phase Phase 4

Sponsor

Margaux M. Salas, PhD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06414356

The ClinicalTrials.gov registry entry for NCT06414356 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (90% lower). The listed sponsor is Margaux M. Salas, PhD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 3 interventions - of which Ketamine is the first listed.

NCT06414356 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06414356 about?

NCT06414356 is a clinical study titled "The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD". This study is aimed to evaluate outpatient ketamine infusion within a military chronic neuropathic pain population and its effect on PTSD. Currently, this is a pilot study with 30 participants. Participants will be randomized to (1) a moderate dose ketamine, (2) moderate dose ketamine +Mg, or (3) a ...

What is the current status of trial NCT06414356?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2024-10-02. Estimated completion is 2027-05.

What conditions does trial NCT06414356 study?

This clinical trial studies the following conditions: PTSD, Neuropathic Pain.

What interventions are being tested in trial NCT06414356?

The interventions under investigation include: Ketamine (DRUG), Magnesium sulfate (DRUG), Ketamine + Magnesium sulfate (DRUG).

Who is sponsoring clinical trial NCT06414356?

This trial is sponsored by Margaux M. Salas, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06414356 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

PTSD

All registered trials for this condition

Neuropathic Pain

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.